Radiopotentiation of human brain tumor cells by sodium phenylacetate

Cancer Letters

Volumn 142, Issue 2, 1999, Pages 139-146

  Ozawa, Tomoko ^a   Lu, Ronnie M ^a   Hu, Lily J ^a   Lamborn, Kathleen R ^a   Prados, Michael D ^a   Deen, Dennis F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Glioblastoma; Hypoxia; Medulloblastoma; Phenylacetate; Radiopotentiation

Indexed keywords

PHENYLACETIC ACID;

ARTICLE; BRAIN TUMOR; CONTROLLED STUDY; CYTOTOXICITY; GLIOMA CELL; HUMAN; HUMAN CELL; HYPOXIC CELL; IN VITRO STUDY; PRIORITY JOURNAL; RADIATION RESPONSE;

BRAIN NEOPLASMS; CELL DIVISION; CELL HYPOXIA; CELL SURVIVAL; GLIOBLASTOMA; HUMANS; MEDULLOBLASTOMA; PHENYLACETATES; RADIATION-SENSITIZING AGENTS; TUMOR CELLS, CULTURED;

EID: 0032974243     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(99)00113-5     Document Type: Article

References (20)

1. Levin V.A., Silver P., Hannigan J., Davis R.L., Wilson C.B. Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarbazine, and vincristine (PCV) over BCNU for anaplastic gliomas: 6G61 final report. Int. J. Radiat. Oncol. Biol. Phys. 18:1990;321-324.
2. Recht L. Preirradiation chemotherapy of supratentorial malignant primary brain tumors with intracarotid cis-platinum (CDDP) and i.v. BCNU. A phase II trial. Am. J. Clin. Oncol. 13:1990;125-131.
3. Burger P.C., Scheithauer B.W., Vogel F.S. Surgical Pathology of the Nervous System and its Coverings. vol. 3 :1991;Churchill Livingstone, New York. pp. 193-196.
4. James M.O., Smith R.L., Williams F.R.S., Reidenberg M. The conjugation of phenylacetic acid in man, sub-human primates and some non-primate species. Proc. R. Soc. Lond. Ser. B. 182:1972;25-35.
5. Weber G. Biochemical strategy of cancer cells and the design of chemotherapy: G.H.A. Clowes Memorial Lecture. Cancer Res. 43:1983;3466-3492.
6. Roberts E., Simonsen D.G. Edsall J.T. Amino Acids, Proteins and Cancer Biochemistry. 1960;121 Academic Press, New York.
7. Neish W.J.P. Phenylacetic acid as a potential therapeutic agent for the treatment of human cancer. Experientia. 27:1971;860-861.
8. Samid D., Shack S., Sherman L.T. Phenylacetate: a novel nontoxic inducer of tumor cell differentiation. Cancer Res. 52:1992;1988-1992.
9. Samid D., Ram Z., Hudgins W.R., Shack S., Liu L., Walbridge S., Oldfield E.H., Myers C.E. Selective activity of phenylacetate against malignant gliomas: resemblance to fetal brain damage in phenylketonuria. Cancer Res. 54:1994;891-895.
10. Ram Z., Samid D., Walbridge S., Oshiro E.M., Viola J.J., Tao-Cheng J., Shack S., Thibault A., Myers C.E., Oldfield E.H. Growth inhibition, tumor maturation, and extended survival in experimental brain tumors in rats treated with phenylacetate. Cancer Res. 54:1994;2923-2927.
11. Stockhammer G., Manley G.T., Johnson R., Rosenblum M.K., Samid D., Liberman F.S. Inhibition of proliferation and induction of differentiation in medulloblastoma- and astrocytoma-derived cell lines with phenylacetate. J. Neurosurg. 83:1995;672-681.
12. Thibault A., Cooper M.R., Figg W.D., Venzon D.J., Sartor A.O., Tompkins A.C., Weinberger M.S., Headlee D.J., McCall N.A., Samid D., Myers C.E. A phase I and pharmacokinetic study of intravenous phenylacetate in patients with cancer. Cancer Res. 54:1994;1690-1694.
13. Miller A.C., Whittaker T., Thibault A., Samid D. Modulation of radiation response of human tumour cells by the differentiation inducer, phenylacetate and phenylbutyrate. Int. J. Radiat. Biol. 72:1997;211-218.
14. Hall E.J. The oxygen effect and reoxygenation. Radiobiology for the Radiologist. vol. 3 :1998;137 J.B. Lippincott, Philadelphia.
15. Gupta N., Lamborn K., Deen D.F. A statistical approach for analyzing clonogenic survival data. Radiat. Res. 145:1996;636-640.
16. Fertil B., Malaise E.P. Inherent cellular radiation as a basic concept for human tumor radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 7:1981;621-629.
17. Shrieve D.C., Deen D.F., Harris J.W. Effects of extreme hypoxia on the growth and viability of EMT6/SF mouse tumor cells in vitro. Cancer Res. 43:1983;3521-3527.
18. Hall E.J. Radiosensitivity and cell age in the mitotic cycle. Radiobiology for the Radiologist. vol. 3 :1998;91 J.B. Lippincott, Philadelphia.
19. Kayama T., Yoshimoto T., Fujimoto S., Sakurai Y. Intratumoral oxygen pressure in malignant brain tumor. J. Neurosurg. 74:1991;55-59.
20. 2 distribution and bioreductive enzymes in human malignant brain tumors. Int. J. Radiat. Oncol. Biol. Phys. 29:1994;427-431.